Drug Type Small molecule drug |
Synonyms TCH-1116 |
Target |
Mechanism PKC inhibitors(Protein kinase C inhibitors), Signal transduction pathway inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | CN | 01 May 2012 |